TABLE 1.
Clinical characteristics
| Variables | All patients | Patients without BM | Patients with BM | p value | Patients with an equivocal AS‐MRI | p value a |
|---|---|---|---|---|---|---|
| Patient no. (%) | 503 | 409 (81.3%) | 88 (17.5%) | ‐ | 6 (1.2%) | ‐ |
| Age, year | 0.031 | 0.122 | ||||
| Median | 72 | 70 | 72 | 73 | ||
| Range | 45–87 | 45–86 | 52–87 | 71–83 | ||
| Clinical T stage, no. (%) | <0.001 | 0.006 | ||||
| Organ confined (<T3) | 246 (48.9) | 236 (57.7) | 7 (7.6) | 3 (50) | ||
| Locally advanced (≥T3) | 257 (51.1) | 173 (42.3) | 81 (92) | 3 (50) | ||
| PSA ng/ml | <0.001 | 0.028 | ||||
| Mean (95% CI) | 34.8 (29.6–40.0) | 24.7 (21.7–27.7) | 99 (69.1–129.9) | 33.4 (10.5–56.3) | ||
| PSA, ng/ml, no. (%) | ‐ | ‐ | ||||
| <10 | 146 (29.1) | 138 (33.7) | 8 (9.1) | 0 | ||
| 10.1–19.9 | 147 (29.2) | 135 (33) | 9 (10.2) | 3 (50) | ||
| 20–49.9 | 120 (23.9) | 102 (24.9) | 16 (18.1) | 2 (33.3) | ||
| >50 | 85 (16.9) | 30 (7.3) | 54 (61.4) | 1 (16.7) | ||
| Gleason score, no. (%) | <0.001 | 0.023 | ||||
| ≤6 | 26 (5.2) | 26 (6.4) | 0 | 0 | ||
| 3 + 4 | 117 (23.3) | 111 (27.1) | 6 (6.8) | 0 | ||
| 4 + 3 | 35 (6.9) | 23 (5.6) | 9 (10.2) | 3 (50) | ||
| ≥8 | 325 (64.8) | 249 (60.1) | 73 (82.9) | 3 (50) | ||
a
Compared with patients with BM.